You are here:
NICE
NICE Guidance
Published Guidance
Infliximab for subacute manifestations of ulcerative colitis
Technology appraisal guidance
Reference number:
TA140
Published:
23 April 2008
This guidance has been updated and replaced by
NICE technology appraisal guidance 329
.